BRIDGENE BIOSCIENCES
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.
BRIDGENE BIOSCIENCES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.bridgenebio.com
Total Employee:
1+
Status:
Active
Contact:
.(408) 498-8127
Email Addresses:
[email protected]
Total Funding:
50.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Mobile Non Scaleable Content Nginx Amazon
Current Employees Featured
Founder
Investors List
Dyee Capital
Dyee Capital investment in Series B - BridGene Biosciences
Junson Capital
Junson Capital investment in Series B - BridGene Biosciences
Lapam Capital
Lapam Capital investment in Series B - BridGene Biosciences
Kaitai Capital
Kaitai Capital investment in Series A - BridGene Biosciences
Takeda Ventures
Takeda Ventures investment in Series A - BridGene Biosciences
WeDo Capital Management
WeDo Capital Management investment in Series A - BridGene Biosciences
Pangu Venture Capital
Pangu Venture Capital investment in Series A - BridGene Biosciences
Official Site Inspections
http://www.bridgenebio.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 15.197.142.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
